BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Anulex Technologies, Inc. 

5600 Rowland Road
Suite 280
Minnetonka  Minnesota  55343  U.S.A.
Phone: 952-224-4000 Fax: 952-224-4040


SEARCH JOBS




Industry
Medical Device






 Company News
Judge Dismisses Anulex Technologies, Inc. From Xclose Off-Label Lawsuit 6/11/2014 6:56:32 AM
Anulex Technologies, Inc. Announces Results From the Prospective Randomized Controlled Study of Anular Repair Published in Spine 8/5/2013 9:44:43 AM
Anulex Technologies, Inc. Announces FDA Clearance for Expanded Indications of fiXate™ Tissue Band 4/4/2012 7:14:01 AM
Anulex Technologies, Inc. Resolves FDA Warning Letter 3/21/2012 6:52:52 AM
Anulex Technologies, Inc. Announces FDA Clearance of the fiXate™ Tissue Band 9/20/2011 10:05:23 AM
Layoffs Occur at Anulex Technologies, Inc. Following FDA’s Warning Letter 4/20/2011 8:10:38 AM
Anulex Technologies, Inc. to Raise a Minimum of $20 Million in Series E Financing 6/3/2010 1:42:14 PM
Anulex Technologies, Inc. Pulls in $4 million 3/26/2010 9:23:28 AM
Anulex Technologies, Inc. Announces the Launch of the Xclose(TM) Plus Tissue Repair System and Achieves 7,300 Patients Treated Milestone 2/18/2010 9:22:19 AM
Anulex Technologies, Inc. Completes Patient Enrollment Phase of Post Market Study and Announces the Treatment of over 6,000 Patients with the Xclose(TM) Tissue Repair System 11/10/2009 10:06:07 AM
12